Mesa Laboratories, Inc.
MLAB
$103.99
$4.204.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.11M | -1.68M | 3.43M | 3.39M | -254.58M |
| Total Depreciation and Amortization | 7.50M | 5.50M | 6.07M | 5.47M | 6.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.60M | 11.06M | 1.78M | 1.92M | 252.61M |
| Change in Net Operating Assets | 9.69M | 3.56M | -6.01M | -338.00K | 8.56M |
| Cash from Operations | 12.67M | 18.44M | 5.27M | 10.43M | 12.88M |
| Capital Expenditure | -757.00K | -813.00K | -1.79M | -891.00K | -535.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 961.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -250.00K | -- | -- | -- | -- |
| Cash from Investing | -1.01M | -813.00K | -1.79M | -891.00K | 426.00K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 73.47M | 0.00 |
| Total Debt Repaid | -17.94M | -9.75M | -7.44M | -80.69M | -11.50M |
| Issuance of Common Stock | 2.64M | -- | -- | -- | 358.00K |
| Repurchase of Common Stock | -887.00K | -- | -- | -- | -728.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -870.00K | -869.00K | -866.00K | -863.00K | -864.00K |
| Other Financing Activities | 858.00K | 20.00K | -307.00K | -1.02M | -199.00K |
| Cash from Financing | -16.19M | -10.60M | -8.61M | -9.11M | -12.93M |
| Foreign Exchange rate Adjustments | 900.00K | -410.00K | 992.00K | -175.00K | -386.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.64M | 6.62M | -4.14M | 258.00K | -10.00K |